Gil Alcoforado
Zero Peri-Implantitis – The Prevention Concept in Implant Dentistry
- Degree in Dentistry from the University of Lisbon (1980). Specialist in Periodontology from the University of Bergen (1981–1983). Fellow of the International College of Dentists (June 1985).
- Regent for Portugal since 2009, president from June 2019 and organizer of the Annual Congress in Porto in June (2022). Invited Researcher – University of Pennsylvania, USA (1986). Invited Professor at the University of Michigan (1989-1990).
- PhD from the University of Lisbon (1995). Tenure from the same University (1999). Invited Professor at the University of Southern California, USA (1998–to date).
- Vice Dean of the Faculty of Dental Medicine of the University of Lisbon (2000-2004). Full Professor (2001- August 2014). Invited Professor at the University of Pennsylvania, USA (2002-2006).
- Founder of the Portuguese Society of Periodontology and Implants (SPPI) and the European Federation of Periodontology (EFP). President of the European Federation of Periodontology (EFP) in 1996/1997.
- Board Member of the IADR (Continental Division) from 2001 to 2004. President of the AG of the Portuguese Dental Association from 2006-2009. Fellow of the American College of Dentists since October 2009.
- “European Association of Osseointegration” (EAO). Elected to the Board in October 2012. Responsible for the “Master Clinician Courses” until 2017. Chairman of the Education Committee from 2017. Treasurer since October 2020.
- Secretary General since September 2022. President since October 2024. Rector of the Egas Moniz University Institute since June 2018. Member of the Lisbon Academy of Sciences since June 2020.
- Has given more than 230 lectures in 23 different countries.
Nationality: Portugal
Scientific areas: Dental Industry Forum (Patent)
7 of november, from 14h30 until 19h00
Dental Industry Forum
Conference summary
Soft tissue bond – the missing element for a dynamic peri-implant defense barrier
For the first time, a biochemical bond between the peri-implant soft-tissue and a transmucosal synthetic element was histologically observed and scientifically documented. This newly discovered soft-tissue bond plays a critical role in maintaining long-term peri-implant health by creating a dynamic defense against downward migration of plaque, inflammation and disease progression.
Early soft-tissue healing – the foundation for predictable long-term esthetics
Immediate soft-tissue behavior during early healing is a key determinant of long-term esthetic outcomes. The soft-tissue response around synthetic implant, abutment or crown characteristics impacts short-, mid- and long-term treatment outcomes. Hence, the foundation for long-lasting esthetic results is laid at the time of implant placement.
What is the best alternative: “Tissue level” or “bone level” implants? Results after 36 years of clinical implantology
Since the establishment of the concept of osseointegration, the use of endosseous implants has continued to grow. The first evidence of lost implants is attributed to the Mayan civilization around 600 AD. During this period, many attempts to replace missing teeth were made, using a wide range of materials and very different techniques to keep them in place.
After a slow start, dental implants began to be used in patients with increasing frequency. Indications developed as implants were perfected in terms of their shapes, designs, surface treatments and connections.
Over time, mechanical and biological problems began to emerge. Mechanical failures led to further developments in implant design. Biological problems took longer to be understood and for approaches to treating these new pathologies to emerge. Inflammations of soft and hard tissues adjacent to implants were diagnosed and treatment protocols were developed.
The annual global dental implant market has grown enormously, with an estimated 12 to 18 million implants sold, while in Europe alone the annual market is estimated at around 5.5 to 6 million implants.
According to statistics from the American Dental Association, 5 million implants are placed annually in the USA alone. Given that peri-implant mucositis and peri-implantitis are highly prevalent and their treatment is challenging, unpredictable and associated with significant morbidity, these results will lead to a rate of 2.64 to 4 million cases of peri-implantitis worldwide.
See the other speakers at the Industry Forum.
Bronze Sponsor
